| 000 -LEADER |
|---|
| fixed length control field |
03668cam a2200361Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20191001103101.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
101206s2011 nyua ob 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781603271974 |
|
|---|
| Cancelled/invalid ISBN |
160327197x |
| 041 ## - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS201.N35 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
22 |
| Item number |
C469 |
| 245 00 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Characterization of nanoparticles intended for drug delivery / |
| Statement of responsibility, etc |
edited by Scott E. McNeil. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York, N.Y. : |
| Name of publisher, distributor, etc |
Humana Press, |
| Date of publication, distribution, etc |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xii, 269 p. : |
| Other physical details |
ill. (some col.) |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Springer protocols. |
| 9 (RLIN) |
3585 |
|
|---|
| Title |
Methods in molecular biology (Clifton, N.J.) ; |
| Volume number/sequential designation |
697. |
| International Standard Serial Number |
1940-6029 ; |
| 9 (RLIN) |
3586 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Unique benefits of nanotechnology to drug delivery and diagnostics -- Challenges for nanoparticle characterization -- Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review -- Measuring the hydrodynamic size of nanoparticles in aqueous media using batch-mode dynamic light scattering -- Characterization of nanoparticles by matrix assisted laser desorption ionization time-of-flight mass spectrometry -- Zeta potential measurement -- Size measurement of nanoparticles using atomic force microscopy -- Biological tissue and cell culture specimen preparation for TEM nanoparticle characterization -- SEM x-ray microanalysis of nanoparticles present in tissue or cultured cell thin sections -- Detecting and measuring free gadolinium in nanoparticles for MRI imaging -- Lipid component quantitation by thin layer chromatography -- Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays -- Analysis of microbial contamination in nanoparticle formulations -- Gold nanoparticle quantitation via fluorescence in solution and cell culture -- Quantitation of nanoparticles in serum matrix by capillary electrophoresis -- Evaluation of cytotoxicity of nanoparticulate materials in porcine kidney cells and human hepatocarcinoma cells -- Monitoring nanoparticle-treated hepatocarcinoma cells for apoptosis -- Detecting reactive oxygen species in primary hepatocytes treated with nanoparticles -- Assay to detect lipid peroxidation upon exposure to nanoparticles -- Monitoring glutathione homeostasis in nanoparticle-treated hepatocytes -- Autophagy monitoring assay: Qualitative analysis of MAP LC3-I to II conversion by immunoblot -- Monitoring lysosomal activity in nanoparticle-treated cells -- Method for analysis of nanoparticle hemolytic properties in vitro -- Method for in vitro analysis of nanoparticle thrombogenic properties -- Qualitative analysis of total complement activation by nanoparticles -- Method for analysis of nanoparticle effects on cellular chemotaxis -- In vitro analysis of nanoparticle uptake by macrophages using chemiluminescence. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nanoparticles |
| General subdivision |
Properties. |
| 9 (RLIN) |
15408 |
|
|---|
| Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
| 9 (RLIN) |
4192 |
|
|---|
| Topical term or geographic name as entry element |
Nanoparticles |
| General subdivision |
therapeutic use. |
| 9 (RLIN) |
15409 |
|
|---|
| Topical term or geographic name as entry element |
Drug delivery systems. |
| 9 (RLIN) |
3648 |
|
|---|
| Topical term or geographic name as entry element |
Nanotechnology. |
| 9 (RLIN) |
1681 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
McNeil, Scott E. |
| 9 (RLIN) |
15410 |
| Relator term |
editor |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Print version: |
| Title |
Characterization of nanoparticles intended for drug delivery. |
| Place, publisher, and date of publication |
New York, N.Y. : |
| Edition |
Humana Press, 2011 |
| International Standard Book Number |
9781603271974 |
| Record control number |
(OCoLC)651075337. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Springer protocols. |
| 9 (RLIN) |
3585 |
|
|---|
| Uniform title |
Methods in molecular biology (Clifton, N.J.) ; |
| Volume number/sequential designation |
v. 697. |
| 9 (RLIN) |
15411 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
SpringerLink |
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-60327-198-1 |
| Public note |
Resource online |
|
|---|
| Materials specified |
SpringerLink |
| Uniform Resource Identifier |
http://www.springerprotocols.com/doiresolver?genre=book&pid=10.1007/978-1-60327-198-1 |
| Public note |
Resource online |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
